23Jan
Blog: Cooley's 2019 Life Sciences M&A Year in Review
2019 was a banner year for billion-dollar life sciences M&A transactions. A wave of big-ticket transactions by global pharmaceutical companies drove life sciences M&A activity to its fourth-largest year on record in 2019, with aggregate deal value in...
By:
Cooley LLP
Related
Members of Congress are already seizing on the moment of rebuilding to re-enter a bipartisan bill to...
Read More >
In this episode of Trekking Through Compliance, we consider the episode Day of the Dove which aired ...
Read More >
As a result of developments relating to the COVID-19 coronavirus pandemic, the Premerger Notificatio...
Read More >
Here is a list of the planned agenda items for That 401(k) National Conference on March 10-11, 2020....
Read More >
Seyfarth Synopsis: Last week the EEOC submitted a status report in the litigation concerning the EEO...
Read More >
Many asset deals have hidden risks that can prove costly for buyers if not addressed prior to closin...
Read More >